08 Apr Cliniceval Solutions, LLC announces expansion of clinical development service offerings to include market research capabilities
(Cincinnati, OH, USA – April 08 2019) – Cliniceval Solutions, LLC announces an expansion in clinical development service offerings to include market research and strategic marketing and communications support. The expanded service offerings will complement Cliniceval Solutions’ current clinical trial feasibility assessment and research site-selection business model and provide enhanced support to pharmaceutical, biotechnology, medical device and medical diagnostic partners at critical stages along the clinical development pathway.
“We are pleased to announce these very important additions to our service portfolio,” said Jim Westerkamp, President. “Our client-base has expressed an increasing need to identify a clinically-focused organization, with established relationships and access to multi-therapeutic Key Opinion Leaders and healthcare stakeholders, to assist in their clinical market research and strategic development efforts. Our leadership team has been integrally involved in the clinical research and development space their entire careers and looks forward to providing valuable market research support on behalf of our partners. Cliniceval Solutions will address a current gap on behalf of the clinical development community by offering a combined clinical and market research perspective. This unique approach will allow our partners to more accurately inform current and future clinical program decisions and help expedite the development of novel therapies for patients in need.”
Cliniceval Solutions will leverage ClinicEval Connect, a global opt-in database including key information and metrics on more than 10,000 multi-therapeutic Key Opinion Leaders and Principal Investigators, to facilitate quantitative and qualitative market research data collection. Additional service offerings related to clinical, marketing and communications support include strategic marketing and collateral development, educational material development, grant application strategy, clinical trial protocol development, manuscript preparation, and formulation of communications strategy.
“Our expansion into the clinical market research and strategic marketing and communications areas is a response to the needs of our partners and aligns with our expertise and overall organizational mission. To ensure we are able to provide the support our partners have come to expect, we are in the process of expanding our global team and we look forward to announcing these additions in the near future,” added Westerkamp.